The global aesthetic and skincare markets are booming, driven by an insatiable demand for innovative, effective, and safe bioactive ingredients. Consumers are no longer satisfied with superficial solu...
Gene-Biocon Biological Technology Co., Ltd. (Hereinafter referred to as: Gene-Biocon), as a leading manufacturer of highly active biologic raw materials, provides the critical foundation for the next ...
Introduction: The Scaffolding Role of Growth Factors in Cellular AgricultureCultivated meat production faces a fundamental challenge: efficiently replicating in vivo muscle development in vitro at ind...
Semaglutide, a glucagon-like peptide-1 (GLP-1) receptor agonist, has revolutionized the treatment of type 2 diabetes and obesity. As a critical component in Semaglutide synthesis, the 29-peptide inter...
Zhuhai Gene-Biocon Biological Technology Co., Ltd., a leader in high-activity biological raw materials, invites you to connect with our team at CPHI 2025 (Booth #W8B76 | Shanghai, Jun 24–26).Why Partner...
Why Recombinant Small-Molecular Collagen?Collagen depletion is the root of aging—wrinkles, sagging, and weakened skin barriers. Traditional collagen supplements face critical limitations:Low bio-avai...
Dear partner,We'd like to thank you for taking the time to connect with us at PCHI 2025. It was truly a pleasure meeting you in person and discussing how we can collaborate to enhance your marketi...
Zhuhai Gene-Biocon Biological Technology Co., Ltd. offers Semaglutide Intermediate P29, a critical building block for synthesizing Semaglutide—a leading GLP-1 analog used in diabetes management. Enginee...
All products from the site for Research Use Only. Not for use in diagnostic procedures.
Reproduction of any materials is strictly forbidden without permission.
We use cookies on this site, including third party cookies, to deliver experience for you.
All products from the site for Research Use Only. Not for use in diagnostic procedures.
Reproduction of any materials is strictly forbidden without permission.